Trial intelligence / Profile preview

Tapentadol effects on endogenous pain modulation in neuropathic pain

NL-OMON34371Recruiting

Sponsor
Leiden University Medical Center
Start
Mar 2011
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in Neuralgia and diabetic polyneuropathy (DPN) comparing Tapentadol, Morphine and Placebo (3 arms). Primary endpoints: Diffuse noxious inhibitory control and Offset analgesia. Started Mar 2011; status: recruiting.

02

Drugs

tapentadolmorphine
03

Conditions

Neuralgiadiabetic polyneuropathy (DPN)

Beyond the preview

Go deeper on NL-OMON34371.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON34371.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call